Stryker Corp. operates in 2 segments: MedSurg and Neurotechnology and Orthopaedics and Spine.
Paying user area
Try for free
Stryker Corp. pages available for free this week:
- Income Statement
- Statement of Comprehensive Income
- Analysis of Solvency Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to EBITDA (EV/EBITDA)
- Price to FCFE (P/FCFE)
- Net Profit Margin since 2005
- Operating Profit Margin since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Stryker Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Segment Profit Margin
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment profit margin ratio improved from 2019 to 2020 and from 2020 to 2021. |
Orthopaedics and Spine | Orthopaedics and Spine segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment Profit Margin: MedSurg and Neurotechnology
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Segment operating income | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Segment operating income ÷ Net sales
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment profit margin ratio improved from 2019 to 2020 and from 2020 to 2021. |
Segment Profit Margin: Orthopaedics and Spine
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Segment operating income | |||||
Net sales | |||||
Segment Profitability Ratio | |||||
Segment profit margin1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment profit margin = 100 × Segment operating income ÷ Net sales
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment profit margin | Orthopaedics and Spine | Orthopaedics and Spine segment profit margin ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment Return on Assets (Segment ROA)
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment ROA | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment ROA improved from 2019 to 2020 and from 2020 to 2021. |
Orthopaedics and Spine | Orthopaedics and Spine segment ROA deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment ROA: MedSurg and Neurotechnology
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Segment operating income | |||||
Assets | |||||
Segment Profitability Ratio | |||||
Segment ROA1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment ROA = 100 × Segment operating income ÷ Assets
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment ROA | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment ROA improved from 2019 to 2020 and from 2020 to 2021. |
Segment ROA: Orthopaedics and Spine
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Segment operating income | |||||
Assets | |||||
Segment Profitability Ratio | |||||
Segment ROA1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment ROA = 100 × Segment operating income ÷ Assets
= 100 × ÷ =
Segment profitability ratio | Reportable segment | The company |
---|---|---|
Segment ROA | Orthopaedics and Spine | Orthopaedics and Spine segment ROA deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment Asset Turnover
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Segment activity ratio | Reportable segment | The company |
---|---|---|
Segment asset turnover | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021. |
Orthopaedics and Spine | Orthopaedics and Spine segment asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment Asset Turnover: MedSurg and Neurotechnology
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Net sales | |||||
Assets | |||||
Segment Activity Ratio | |||||
Segment asset turnover1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment asset turnover = Net sales ÷ Assets
= ÷ =
Segment activity ratio | Reportable segment | The company |
---|---|---|
Segment asset turnover | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment asset turnover ratio improved from 2019 to 2020 and from 2020 to 2021. |
Segment Asset Turnover: Orthopaedics and Spine
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Net sales | |||||
Assets | |||||
Segment Activity Ratio | |||||
Segment asset turnover1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment asset turnover = Net sales ÷ Assets
= ÷ =
Segment activity ratio | Reportable segment | The company |
---|---|---|
Segment asset turnover | Orthopaedics and Spine | Orthopaedics and Spine segment asset turnover ratio deteriorated from 2019 to 2020 but then slightly improved from 2020 to 2021. |
Segment Capital Expenditures to Depreciation
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Segment financial ratio | Reportable segment | The company |
---|---|---|
Segment capital expenditures to depreciation | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment capital expenditures to depreciation ratio deteriorated from 2019 to 2020 and from 2020 to 2021. |
Orthopaedics and Spine | Orthopaedics and Spine segment capital expenditures to depreciation ratio improved from 2019 to 2020 but then deteriorated significantly from 2020 to 2021. |
Segment Capital Expenditures to Depreciation: MedSurg and Neurotechnology
Stryker Corp.; MedSurg and Neurotechnology; segment capital expenditures to depreciation calculation
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Purchases of property, plant and equipment | |||||
Depreciation and amortization | |||||
Segment Financial Ratio | |||||
Segment capital expenditures to depreciation1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment capital expenditures to depreciation = Purchases of property, plant and equipment ÷ Depreciation and amortization
= ÷ =
Segment financial ratio | Reportable segment | The company |
---|---|---|
Segment capital expenditures to depreciation | MedSurg and Neurotechnology | MedSurg and Neurotechnology segment capital expenditures to depreciation ratio deteriorated from 2019 to 2020 and from 2020 to 2021. |
Segment Capital Expenditures to Depreciation: Orthopaedics and Spine
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
Selected Financial Data (US$ in millions) | |||||
Purchases of property, plant and equipment | |||||
Depreciation and amortization | |||||
Segment Financial Ratio | |||||
Segment capital expenditures to depreciation1 |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
1 2021 Calculation
Segment capital expenditures to depreciation = Purchases of property, plant and equipment ÷ Depreciation and amortization
= ÷ =
Segment financial ratio | Reportable segment | The company |
---|---|---|
Segment capital expenditures to depreciation | Orthopaedics and Spine | Orthopaedics and Spine segment capital expenditures to depreciation ratio improved from 2019 to 2020 but then deteriorated significantly from 2020 to 2021. |
Net sales
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine | |||||
Total |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Depreciation and amortization
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine | |||||
Corporate and Other | |||||
Total |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Segment operating income
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine | |||||
Total |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Assets
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine | |||||
Corporate and Other | |||||
Total |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Purchases of property, plant and equipment
Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | |
---|---|---|---|---|---|
MedSurg and Neurotechnology | |||||
Orthopaedics and Spine | |||||
Corporate and Other | |||||
Total |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).